Axonics SacRal NeuromodulaTIon System RegisTRY Study

NCT05064384 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 272

Last updated 2025-09-22

Study results available
· View outcomes & findings →

Summary

To assess the post-market clinical outcomes with use of the Axonics Sacral Neuromodulation System(s).

Conditions

  • Urinary Retention
  • Urinary Urge Incontinence
  • Urgency-Frequency
  • Fecal Incontinence

Sponsors & Collaborators

  • Axonics, Inc.

    lead INDUSTRY

Principal Investigators

  • Karen Noblett, MD · Axonics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2023-10-06
Completion
2024-03-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05064384 on ClinicalTrials.gov